Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 12 Jun 2026 17:30 CEST |
LIFECARE ASA | Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue | 20103010 Biotechnology | Inside information |
| 12 Jun 2026 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Last day of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Jun 2026 08:10 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Jun 2026 16:11 CEST |
LIFECARE ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Jun 2026 07:00 CEST |
LIFECARE ASA | Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response | 20103010 Biotechnology | Non-regulatory press releases |
| 05 Jun 2026 07:00 CEST |
Lifecare ASA | Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Jun 2026 13:15 CEST |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 01 Jun 2026 07:00 CEST |
Lifecare ASA | Lifecare ASA: Commencement of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 May 2026 18:55 CEST |
Lifecare ASA | Lifecare ASA: Exercise price for Warrants Series 2 issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 May 2026 22:03 CEST |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 15 May 2026 07:00 CEST |
Lifecare ASA | LIFE: Lifecare ASA Q1 2026 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 07 May 2026 18:30 CEST |
Lifecare ASA | Lifecare ASA (LIFE): Invitation to Q1 2026 results presentation | 20103010 Biotechnology | Non-regulatory press releases |
| 07 May 2026 18:27 CEST |
Lifecare ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Apr 2026 10:58 CEST |
Lifecare ASA | Minutes from Annual General meeting 2026 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Apr 2026 22:00 CEST |
Lifecare ASA | Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 01 Apr 2026 11:27 CEST |
Lifecare ASA | Flaggemelding | 20103010 Biotechnology | Flagging |
| 01 Apr 2026 11:27 CEST |
Lifecare ASA | Disclosure of shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 27 Mar 2026 11:21 CET |
Lifecare ASA | Shareholding disclosure - Nordnet AB (publ) 2 | 20103010 Biotechnology | Major shareholding notifications |
| 27 Mar 2026 11:14 CET |
Lifecare ASA | Shareholding disclosure - Nordnet AB (publ) | 20103010 Biotechnology | Major shareholding notifications |
| 26 Mar 2026 15:02 CET |
Lifecare ASA | Lifecare ASA Operational restructuring to support transition to production and centralization of operations | 20103010 Biotechnology | Inside information |
| 26 Mar 2026 08:05 CET |
Lifecare ASA | Flaggemelding Lifecare ASA | 20103010 Biotechnology | Flagging |
| 25 Mar 2026 13:49 CET |
Lifecare ASA | Lifecare ASA: Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 24 Mar 2026 07:01 CET |
Lifecare ASA | Lifecare ASA Annual Report 2025 | 20103010 Biotechnology | Annual financial and audit Reports |
| 20 Mar 2026 15:31 CET |
Lifecare ASA | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Mar 2026 12:08 CET |
Lifecare ASA | Disclosure of shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 16 Mar 2026 12:08 CET |
Lifecare ASA | Flaggemelding | 20103010 Biotechnology | Flagging |
| 13 Mar 2026 23:37 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 13 Mar 2026 20:03 CET |
Lifecare ASA | Lifecare ASA - Chief Scientific Officer to step down from executive role | 20103010 Biotechnology | Inside information |
| 13 Mar 2026 17:55 CET |
Lifecare ASA | Lifecare ASA: Final results following expiry of exercise period for Warrants Series 1 issued in connection with Rights Issue | 20103010 Biotechnology | Inside information |
| 13 Mar 2026 16:49 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 13 Mar 2026 08:48 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 13 Mar 2026 07:00 CET |
Lifecare ASA | Lifecare ASA: Last day of the Exercise Period for Warrants Series 1 issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Mar 2026 07:00 CET |
Lifecare ASA | European Commission recognises Lifecare innovations in implantable glucose monitoring | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Mar 2026 15:29 CET |
Lifecare ASA | Correction: Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 11 Mar 2026 14:28 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Mar 2026 13:38 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 10 Mar 2026 08:15 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 09 Mar 2026 22:34 CET |
Lifecare ASA | Lifecare ASA receives regulatory feedback on first-in-human application, and has engaged Link Medical as advisor for a re-submission | 20103010 Biotechnology | Inside information |
| 09 Mar 2026 13:09 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 06 Mar 2026 14:14 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 06 Mar 2026 09:01 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 06 Mar 2026 07:00 CET |
Lifecare ASA | Lifecare ASA: Last day of trading in Warrants Series 1 issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Mar 2026 10:40 CET |
Lifecare ASA | Lifecare ASA: Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 05 Mar 2026 07:00 CET |
Lifecare ASA | Lifecare confirms 12-week implant stability under real-life conditions materially reduces durability risk ahead of first-in-human study | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Mar 2026 07:00 CET |
Lifecare ASA | LIFE: Lifecare ASA Q4 2025 results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 02 Mar 2026 07:00 CET |
Lifecare ASA | Lifecare ASA: Commencement of the Exercise Period for Warrants Series 1 issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Feb 2026 19:06 CET |
Lifecare ASA | Lifecare ASA: Exercise price for Warrants Series 1 issued in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Feb 2026 07:00 CET |
Lifecare ASA | Lifecare reaches regulatory milestone - veterinary product cleared for sales in Europe | 20103010 Biotechnology | Inside information |
| 25 Feb 2026 07:00 CET |
Lifecare ASA | Lifecare ASA appoints Petter Nielsen as Chief Financial Officer | 20103010 Biotechnology | Inside information |
| 24 Feb 2026 14:30 CET |
Lifecare ASA | Lifecare ASA (LIFE): Invitation to Q4 2025 results presentation | 20103010 Biotechnology | Non-regulatory press releases |